Corporate Travel Management shares plunge 80% as trade resumes after a year

Corporate Travel Management (CTD) shares plunged up to 82.6% to A$2.80 on ASX resumption after a year-long suspension tied to delayed filings and an overcharging scandal. A forensic review found clients were overcharged by more than A$250 million (about £80 million involving the UK government), with the former UK CEO dismissed. Despite reporting A$17.7M net profit for fiscal 2026 vs a A$348.5M loss prior year and securing a A$175M financing package for customer repayments, the stock’s restart risked a sharp repricing.

Analysis

This is less a one-day drawdown than a re-underwriting of the business model. The core damage is not the size of the restitution check; it is that procurement teams now have a concrete reason to re-tender a service that depends on trust, data integrity, and low-friction renewal. That creates a second-order beneficiary set: rivals in corporate travel and adjacent expense/compliance software can poach accounts with minimal price cuts, while CTM’s own operating leverage works in reverse as service-cost ratios rise on a smaller book.

The near-term catalyst path is messy: the first 1-3 months should be dominated by customer retention disclosures, auditor commentary, litigation provisioning, and any evidence that the financing package is merely a bridge to more cash calls. If the repayments and legal costs consume most of free cash flow, the equity story becomes a dilution/covenant watch rather than an earnings recovery. The stock can bounce mechanically on forced-covering, but that is not the same as a durable rerating.

Contrarian view: the market may still be anchoring to reported profit instead of normalized cash generation after restatement and churn. If the client base is mostly intact and the governance fix is credible, the move could ultimately prove overdone. But if even a small number of anchor customers re-platform, the multiple compression can persist for 6-18 months because the business becomes harder to underwrite on recurring trust and less on headline EPS.

Key Decisions for Investors

• Short CTMLF on any liquidity-driven relief rally over the next 1-3 weeks; risk/reward favors fading rebounds until retention and reserve exposure are quantified. Invalidated if management shows stable top-20 client retention and no new cash leakage in the next update.
• If borrow is tight, use a defined-risk CTMLF put spread 3-6 months out to express litigation/custody risk; the thesis is not bankruptcy, it is multiple compression plus cash drag.
• Pair trade: long FLT.AX / short CTMLF for 1-3 months as a relative-quality governance spread. This works only if corporate travel demand stays steady and the market rewards cleaner disclosure over headline profit.
• Do not buy the reported earnings recovery until audited cash flow and net debt are reconciled; treat any rally back toward the pre-suspension range as a sell signal unless client churn is de minimis.